Warren Dehart

Warren DeHart is a seasoned sales professional with extensive experience in the pharmaceutical industry, currently serving as a Senior Neuroscience Sales Specialist at Intra-Cellular Therapies since February 2020, focusing on launching a newly FDA-approved atypical antipsychotic. Prior roles include an Executive Sales Professional at Sanofi, where Warren increased sales for diabetes insulin products, and an Executive Sales Specialist at Shire, managing ADHD product sales. Previous experience encompasses positions at Pfizer, including a Professional Healthcare Representative and a Therapeutic Specialty Representative, achieving multiple sales awards and leading in quota attainment. Warren holds a Master of Business Administration degree specializing in Health Administration and Policy from the University of Miami and a Bachelor of Business Administration in Management from Texas Tech University.